Thomas C Quinn Selected Research

Male Circumcision

11/2017	HIV Prevention Efforts and Incidence of HIV in Uganda.
10/2017	Impact of a community health worker HIV treatment and prevention intervention in an HIV hotspot fishing community in Rakai, Uganda (mLAKE): study protocol for a randomized controlled trial.
11/2015	Herpes Simplex [corrected] Virus Type 2 Shedding From Male Circumcision Wounds in Rakai, Uganda.
4/2015	HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study.
11/2014	Prevention of syphilis: another positive benefit of male circumcision.
3/2014	Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda.
1/2014	Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections.
9/2013	Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda.
7/2013	Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-Saharan African community.
2/2012	Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas C Quinn Research Topics

Disease

65	Infections 10/2022 - 02/2002
30	HIV Infections (HIV Infection) 01/2022 - 08/2002
20	COVID-19 02/2022 - 09/2020
15	Trachoma 01/2022 - 04/2009
11	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2020 - 02/2002
11	Disease Progression 01/2019 - 03/2008
8	Superinfection 01/2019 - 07/2012
7	Ulcer 01/2022 - 11/2009
7	Viremia 01/2022 - 04/2002
7	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 04/2002
7	Measles 10/2009 - 04/2002
6	Papillomavirus Infections 01/2021 - 03/2009
6	Syphilis 01/2019 - 01/2005
5	Inflammation (Inflammations) 01/2022 - 05/2016
5	Herpes Genitalis (Genital Herpes) 08/2015 - 06/2005
4	Coinfection 01/2015 - 04/2002
3	Liver Diseases (Liver Disease) 07/2013 - 01/2011
2	Chronic Disease (Chronic Diseases) 05/2022 - 01/2022
2	Cough 02/2022 - 01/2022
2	Pharyngitis (Sore Throat) 02/2022 - 01/2022
2	Cognitive Dysfunction 01/2021 - 09/2009
2	Persistent Infection 10/2017 - 05/2011
2	Herpes Simplex 03/2016 - 11/2015
2	Malaria 02/2016 - 01/2010
2	Chlamydia Infections 12/2015 - 07/2003
2	Wounds and Injuries (Trauma) 11/2015 - 04/2015
2	Gonorrhea 11/2013 - 02/2002
2	Blindness (Hysterical Blindness) 03/2011 - 04/2009
2	Opportunistic Infections (Opportunistic Infection) 04/2010 - 11/2002
2	Cytomegalovirus Retinitis 10/2002 - 04/2002
2	Retinitis 10/2002 - 04/2002
1	Meningoencephalitis 01/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Eye Infections 12/2019
1	Virus Diseases (Viral Diseases) 08/2015

Drug/Important Bio-Agent (IBA)

20	AntibodiesIBA 02/2022 - 12/2007
19	RNA (Ribonucleic Acid)IBA 10/2021 - 04/2002
13	Immunoglobulin G (IgG)IBA 02/2022 - 03/2002
12	Azithromycin (Zithromax)FDA LinkGeneric 12/2019 - 01/2005
8	EpitopesIBA 05/2022 - 10/2020
8	Neutralizing AntibodiesIBA 01/2022 - 01/2017
8	VaccinesIBA 01/2021 - 10/2006
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2002
6	Pharmaceutical PreparationsIBA 10/2021 - 09/2002
6	Nucleic AcidsIBA 01/2019 - 02/2002
6	AntigensIBA 01/2018 - 04/2009
5	Peptides (Polypeptides)IBA 01/2022 - 10/2020
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 01/2013
5	EnzymesIBA 04/2014 - 10/2002
4	Immunoglobulin M (IgM)IBA 02/2022 - 02/2008
4	CytokinesIBA 02/2021 - 04/2009
4	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2002
4	Interleukin-6 (Interleukin 6)IBA 10/2019 - 04/2011
4	Lipopolysaccharide ReceptorsIBA 11/2015 - 04/2009
4	Measles VaccineIBA 10/2009 - 08/2007
3	N 30IBA 12/2021 - 02/2021
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 05/2016
3	Biological ProductsIBA 10/2017 - 02/2005
3	Acyclovir (Aciclovir)FDA LinkGeneric 01/2017 - 06/2012
3	insulin receptor-related receptor (IRR)IBA 03/2014 - 11/2009
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022 - 12/2021
2	Amino Acids FDA Link 01/2022 - 01/2014
2	Immunoglobulin A (IgA)IBA 07/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 04/2002
2	Interleukin-2 (IL2)IBA 03/2016 - 07/2013
2	Antimalarials (Antimalarial Agents)IBA 02/2016 - 01/2010
2	Glycoproteins (Glycoprotein)IBA 08/2015 - 12/2007
2	AIDS VaccinesIBA 03/2014 - 07/2012
2	Complement System Proteins (Complement)IBA 12/2011 - 04/2009
2	ImmunosorbentsIBA 05/2008 - 12/2007
2	Ligases (Synthetase)IBA 02/2002 - 02/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Blood Group Antigens (Blood Groups)IBA 08/2021
1	ABO Blood-Group SystemIBA 08/2021
1	ChemokinesIBA 02/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	GlobulinsIBA 01/2021
1	ProteomeIBA 10/2020
1	Illicit Drugs (Recreational Drugs)IBA 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Enfuvirtide (Fuzeon)FDA Link 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2018
1	Fatty Acid-Binding ProteinsIBA 05/2016
1	HIV AntibodiesIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Doxycycline (Periostat)FDA LinkGeneric 12/2015

Therapy/Procedure

22	Therapeutics 01/2022 - 04/2002
20	Male Circumcision 11/2017 - 02/2007
11	Art Therapy 01/2022 - 01/2011
8	Mass Drug Administration 01/2020 - 07/2011
6	Highly Active Antiretroviral Therapy (HAART) 02/2005 - 09/2002
5	Condoms (Condom) 01/2022 - 07/2003
2	Continuity of Patient Care 07/2015 - 01/2015
1	Organ Transplantation 10/2022
1	Hand Hygiene 02/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020
1	Transplantation 01/2020